Observational Study to Assess Adverse Events When Adult Female Participants Are Treated With Ubrelvy (Ubrogepant) or Qulipta (Atogepant) During Pregnancy
Clinical trial NCT05158894 · RECRUITING
Trial details
- NCT number
- NCT05158894
- Sponsor
- AbbVie
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-01-10
- Primary completion
- 2036-01-01
- Enrollment
- 1884
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.